Epizyme, Inc.
Substituted Cyclohexylamine Compounds

Last updated:

Abstract:

The present disclosure provides substituted cyclohexylamine compounds having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein R.sup.1, R.sup.2a, R.sup.2b, R.sup.3a, R.sup.3b, R.sup.4, R.sup.5, and R.sup.7 are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula I to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

19 Oct 2018

Issue date:

23 Apr 2020